Sidney Kimmel Cancer Center – Jefferson Health

The Sidney Kimmel Cancer Center (SKCC) at Jefferson Health is a matrixed consortium cancer center that serves the patient population of urban Philadelphia and its adjacent communities by building upon the unique expertise, resources, and capabilities of two highly regarded Philadelphia-based institutions, Thomas Jefferson University and Drexel University. Our members are singularly focused on eradicating the impact of cancer, including disparities and inequities, in our community and beyond through the most advanced clinical care, innovative transdisciplinary research, dynamic training and mentorship, and trusted partnerships with community organizations, families, and civic leaders.

The mission of the SKCC is to improve the lives of cancer patients and their families through compassion, innovation, and breakthrough discoveries. Areas of scientific focus include cancer risk and control, implementation science, cancer health disparities, clinical trials, molecular oncology regulation and approaches, translational and cellular oncology, and immune cell regulation and targeting. Research in each of these areas is needed to successfully unravel the cancer problems within our Catchment Area and enable us to leverage our distinct expertise in understanding the needs of our community, moving catchment-relevant discoveries quickly from the bench to the bedside, and then sharing our findings and implementing interventions within the community.

The SKCC provides access to advanced clinical trials and comprehensive treatment strategies for patients throughout the Delaware Valley via 5 Advanced Care Hub sites in Center City Philadelphia, South Jersey, Northeast Philadelphia, and the northern suburbs of Philadelphia.

Our Catchment Area consists of seven contiguous counties, four in Pennsylvania (Philadelphia, Montgomery, Delaware, and Chester) and three in New Jersey (Burlington, Camden, and Gloucester). Notably, the region has approximately 6.1 million residents; if it were a state, it would be the 20th most populous state in the U.

Thomas Jefferson University

Comp

Andrew Chapman, DO, FACP
Director

833 Chestnut Street
Suite 1140
Philadelphia, PA 19107

215-955-7595

Senior Leaders

Senior Leader	Title
Alessandro Fatatis, MD, PhD	Associate Director for Basic Research
Amy Leader, PhD, MPH	Associate Director for Community Outreach & Engagement
Ana-Maria Lopez, MD	Associate Director for Leadership Development
Andrew Aplin, PhD	Deputy Director
Andrew Chapman, DO	Director and Principal Investigator
Christopher McNair, PhD	Associate Director for Data Science
Elizabeth Schade	Associate Director for Cancer Research Administration
Kenny Simansky, PhD	Senior Consortium Representative
Marja Nevalinen, PhD	Associate Director for Translational Research
Mattias Schnell, PhD	Associate Director for Shared Reources
Nicole Simone, MD	Associate Director for Training & Education
Noreen Robertson, DMD	Consortium Representative
TBN TBN	Associate Director for Population Science
William Kevin Kelly, DO	Associate Director for Clinical Research

Research Programs

Research Program	Program Leaders
Cancer Risk & Control	Kuang-Yi Wen, MD; Theresa Hyslop, PhD
Immune Cell Regulation & Targeting	Adam Snook, PhD; Pierluigi Porcu, MD
Molecular Oncology Regulation & Approaches	Daniel Silver, MD, PhD
Translational & Cellular Oncology	Mauricio Regianto, PhD; Ubaldo Martinez-Outschoorn, MD

Shared Resources

Category	Resource	Directors
Cat 1: Laboratory Science	Bioimaging	Claudio Giraudo, PhD; Philip Wedgaertner, PhD
Cat 1: Laboratory Science	Cancer Genomics	Brian Wigdahl, PhD; Andrew South, PhD
Cat 1: Laboratory Science	Flow Cytometry & Human Immune Monitoring	Larry Harshyne, PhD
Cat 1: Laboratory Science	Integrated Structural Biology	Demitri Temiakov, PhD; Erik Debler, PhD
Cat 4: Clinical Research	Translational Pathology	Hallgeur Rui, MD, PhD; Haifeng Yang, PhD
Cat 6: Biostatistics	Biostatistics, Bioinformatics & Research Informatics	Benjamin Leiby, PhD; Christopher McNair, PhD

Last Updated

August 27, 2026